Iatrogenic cost factors incorporating mild and moderate adverse events in the economic comparison of aceclofenac and other NSAIDs

PharmacoEconomics

Volumn 19, Issue 7, 2001, Pages 779-790

  Peris, Francesc ^a   Martínez, Eduard ^a   Badia, Xavier ^b   Brosa, Max ^c  

^a Almirall Prodesfarma SA ^*  (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c Health Outcomes Research Europe   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACECLOFENAC; DICLOFENAC; INDOMETACIN; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; TENOXICAM;

ABDOMINAL PAIN; ANALGESIA; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL TRIAL; CONSTIPATION; COST BENEFIT ANALYSIS; DECISION THEORY; DERMATITIS; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; ECONOMIC EVALUATION; GASTRODUODENAL ULCER; GASTROESOPHAGEAL REFLUX; HEADACHE; HUMAN; IATROGENIC DISEASE; META ANALYSIS; OSTEOARTHRITIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; VERTIGO; VOMITING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; DICLOFENAC; HEALTH CARE COSTS; HUMANS; OSTEOARTHRITIS; RANDOMIZED CONTROLLED TRIALS; SPONDYLITIS, ANKYLOSING;

EID: 0034922873     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200119070-00006     Document Type: Article

References (30)

1. Treatment compliance and safety of aceclofenac versus standard NSAIDS in patients with common arthritic disorders: A meta-analysis
2. Should nonsteroidal anti-inflammatory drugs be used to treat osteoarthritis?
3. Nonsteroidal anti-inflammatory discontinuation in patients with osteoarthritis
4. The cost of rheumatoid arthritis
5. The economic consequences of NSAID-induced gastropathy: The French context
6. Epidemiology of NSAID-induced gastropathy
7. Measuring the effects of medication use on health-related quality of life in patients with rheumatoid arthritis
8. Treatment of severe rheumatic pain with aceclofenac: Results of comparative study versus placebo
9. Eficacia y tolerancia de aceclofenaco en el tratamiento de la gonartrosis
10. Efficacy and tolerability of aceclofenac versus ketoprofen in the treatment of rheumatoid arthritis
11. Aceclofenac versus naproxen in the treatment of AS: A double-blind, controlled study
12. Evaluation of the efficacy and safety of aceclofenac in the treatment of osteoarthritis
13. Aceclofenac in comparison to ketoprofen in the treatment of rheumatoid arthritis
14. Comparison of aceclofenac with diclofenac in the treatment of osteoarthritis
15. Aceclofenac in the treatment of rheumatoid arthritis: A multicentre, double-blind, randomised, placebo controlled study
16. The iatrogenic cost of nonsteroidal anti-inflammatory drug therapy
17. Economic evaluation of oral sumatriptan compared with oral caffeine/ergotamine for migraine
18. Probabilistic sensitivity analysis incorporating the bootstrap: An example comparing treatments for the eradication of heticobacter pylori
19. Pharmacoeconomics of nonsteroidal anti-inflammatory drugs (NSAIDs)
20. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: Cohort study
21. Choice of NSAID and management strategy in rheumatoid arthritis and osteoarthritis: The impact on costs and outcomes in the UK
22. The use of consensus methods and expert panels in pharmacoeconomic studies: Practical applications and methodological shortcomings
23. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized controlled trial
24. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs